Ching I Ching

Ching I Ching currently works at TAIFLEX Scientific Co., Ltd., as Vice Chairman, Globe Vision Venture Capital Corp., as Chairman, Hua Wei Century Venture Capital Co. Ltd., as Chairman, LandMark Optoelectronics Corp., as Chairman from 2020, Hua Wei International Science & Technology Consulting Co. Ltd, as Chairman, Taiwan Venture Capital Association, as Vice Chairman, CsrCommunity International Ltd., as Chairman, The CID Group (China), as Chairman, CAM-CID Asia Pacific Investment Corp., as Director, A&D Capital Corp., as Director, J&D Capital Corp., as Director, Epoch Foundation, as Director, Hwa Sun International Investment Ltd., as Director, Asia Best Healthcare Co. Ltd., as Director, Hua Ho Wen Chuang Management Consultancy Co. Ltd., as Director, TWi Pharmaceuticals Holding, Inc., as Director, Star Pacific Worldwide Ltd., as Director, LiKer International Information Co. Ltd., as Director, Eurocharm Holdings Co., Ltd., as Director from 2013, C&D Capital II Corp., as Director, How Sweet Bakery, as Director, and Entire Technology Co., Ltd., as Director from 2019.
Dr. Ching also formerly worked at Solomon Systech (International) Ltd., as Non-Executive Director from 2003 to 2010, Kinsus Interconnect Technology Corp., as Director, TWi Pharmaceuticals, Inc., as Director, GEM Services, Inc., as Director, Quanta Computer, Inc., as Member-Supervisory Board, Quanta Storage, Inc., as Member-Supervisory Board, and The CID Group, as Managing Partner from 2014 to 2016.
Dr. Ching received his Masters Business Admin degree from National Chengchi University, doctorate degree from Shanghai Jiao Tong University, and undergraduate degree from National Chung Hsing University.